Protection against nitrofurantoin-induced oxidative stress by coelenterazine analogues and their oxidation products in rat hepatocytes

References

• Campbell A.K., Herring P.J. Imidazolopyrazine bioluminescence in copepods and other marine organisms. Marine Biology 1990; 104: 219–225
   Web of Science ®Google Scholar
• Thompson E.M., Rees J.F. Origins of the luciferins: the ecology of bioluminescence in marine fishes. Biochemistry and Molecular Biology of Fishes, P.W. Hochachka, T.P. Mommsen. Elsevier, Amsterdam and New York 1995; 4: 435–466, In
   Google Scholar
• Rees J.F., de Wergifosse B., Noiset O., Dubuisson M., Janssens B., Thompson E.M. The origins of marine bioluminescence: turning oxygen defence mechanisms into deep-sea communication tools. Journal of experimental Biology 1998; 201: 1211–1221
   PubMed Web of Science ®Google Scholar
• De Wergifosse B., Noiset O., Dubuisson M., Marchand-Brynaert J., Baguet F., Rees J.F. A new function for coelenterazine oxidation product supports the non-bioluminescent evolutionary origin of the luciferin. Bioluminescence and Chemiluminescence. Perspectives for the 21^st Century, A. Roda, M. Pazzagli, L.J. Kricka, P.E. Stanley. John Wiley & Sons, Chichester 1999; 396–399, In
   Google Scholar
• Dubuisson M., de Wergifosse B., Trouet A., Baguet F., Marchand-Brynaert J., Rees J.F. Antioxidative properties of natural coelenterazine and synthetic methyl-coelenterazine in rat hepatocytes submitted to tert-butyl hydroperoxide-induced oxidative stress. Biochemical Pharmacology 2000; 60: 471–478
   PubMed Web of Science ®Google Scholar
• George D.K., Crawford D.H. Antibacterial-induced hepatotoxicity. Incidence, prevention and management. Drug Safety 1996; 15: 79–85
   PubMed Web of Science ®Google Scholar
• Schattner A., Von der Walde J., Kozac N., Sokolovskaya N., Knobler H. Nitrofurantoin-induced immune-mediated lung and liver disease. American Journal of Medical Sciences 1999; 317: 336–340
   PubMed Web of Science ®Google Scholar
• Shen W., Hoener B. Mitigation of nitrofurantoin-induced toxicity in the perfused rat liver. Human experimental Toxicology 1996; 15: 428–434
   PubMedGoogle Scholar
• Minchin R.F., Ho P.C., Boyd M.R. Reductive metabolism of nitrofurantoin by rat lung and liver in vitro. Biochemical Pharmacology 1986; 35: 575–580
   PubMed Web of Science ®Google Scholar
• Suzuki N., Ogawa K., Yoda B., Nomoto T., Inaba H., Goto T. T. Chemiluminescent detection of active oxygen species, singlet molecular oxygen and superoxide, using Cypridinaluciferin analogues. Nippon Suisan Gakkaishi 1991; 57: 1711–1715
   Google Scholar
• Takahama U. Hydrogen peroxide-dependent generation of singlet molecular oxygen by human saliva: its detection by chemiluminescence from a Cypridina luciferin analog. Photochemistry and Photobiology 1993; 57: 376–379
   PubMedGoogle Scholar
• Nakano M., Sugioka K., Ushijima Y., Goto T. Chemiluminescence probe with Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, for estimating the ability of human granulocytes to generate O2.-. Analytical Biochemistry 1986; 159: 363–369
   PubMed Web of Science ®Google Scholar
• Shimomura O., Wu C., Murai A., Nakamura H. Evaluation of five imidazopyrazinone-type chemiluminescent superoxide probes and their application to the measurement of superoxide anion generated by Listeria monocytogenes. Analytical Biochemistry 1998; 258: 230–235
   PubMed Web of Science ®Google Scholar
• Akutsu K., Nakajima H. H., Katoh T., Kino S., Fujimori K. Chemiluminescence of Cypridina luciferin analogs. 2. Kinetic-Studies on the reaction of 2-methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one (CLA) with superoxide — Hydroperoxyl radical is an actual active species used to initiate the reaction. Journal of the Chemical Society: Perkin Transactions 1995; 2: 1699–1706
   Google Scholar
• Tampo Y., Tsukamoto M., Yonaha M. The antioxidant action of 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazo[1,2-alpha]pyrazin-3-one (MCLA), a chemiluminescence probe to detect superoxide anions. Federation of European Biochemical Societies Letters 1998; 430: 348–352
   PubMed Web of Science ®Google Scholar
• Inoue S., Sugiara S., Kakoi H., Hashizume K., Goto T., Iio H. Squid bioluminescence II. Isolation from Watasenia scintillans and synthesis of 2-(p-hydroxybenzyl)-6-(p-hydroxyphenyl)-3,7-dihydroimidazo {1,2-a}pyrazin-3-one. Chemistry Letters 1975; 1975: 141–144
   Google Scholar
• Devillers I., De Wergifosse B., Rees J.F., Marchand-Brynaert J. Synthesis and evaluation of coelenterazine analogs as potential antioxidants useful in medicinal chemistry. Journal of the Chemical Society: Perkin Transactions 1999; 2: 1481–1487
   Google Scholar
• Seglen P.O., Isolation of hepatocytes. Cell Biology: a laboratory handbook. Methods in Cell Biology 1976; 13: 29–83
   PubMedGoogle Scholar
• Donato M.T., Gomez L.M., Castell J.V. A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Analytical Biochemistry 1993; 213: 29–33
   PubMed Web of Science ®Google Scholar
• Kendall J.M., Dormer R.L., Campbell A.K. Targeting aequorin to the endoplasmic reticulum of living cells. Biochemical and Biophysical Research Communications 1992; 189: 1008–1016
   PubMed Web of Science ®Google Scholar
• Youngman R.J., Osswald W.F., Elstner E.F. Mechanisms of oxygen activation by nitrofurantoin and relevance to its toxicity. Biochemical Pharmacology 1982; 31: 3723–3729
   PubMed Web of Science ®Google Scholar
• Goeptar A.R., te Koppele J.M., van Maanen J.M., Zoetemelk C.E., Vermeulen N.P. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450. Biochemical Pharmacology 1992; 43: 343–352
   PubMed Web of Science ®Google Scholar
• Testa B., Jenner P. Inhibitors of P450 and their mechanisms of action. Drug Metabolism and Disposition 1981; 12: 1–117
   Google Scholar
• Maurice M., Pichard L., Daujat M., Fabre I., Joyeux H., Domergue J., Maurel P. Effects of imidazole derivatives on cytochrome P450 from human hepatocytes in primary culture. Federation of American Societies for Experimental Biology Journal 1992; 6: 752–758
   PubMed Web of Science ®Google Scholar
• Bourrie M., Meunier V., Berger Y., Fabre G. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics 1996; 277: 321–332
   PubMed Web of Science ®Google Scholar
• Shiba D., Shimamoto N. Attenuation of endogenous oxidative stress-induced cell death by cytochrome P450 inhibitors in primary cultures of rat hepatocytes. Free Radicals in Biology and Medicine 1999; 27: 1019–1026
   PubMed Web of Science ®Google Scholar